CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 151 filers reported holding CHEMOCENTRYX INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,465,000 | -85.3% | 319,600 | -53.0% | 0.02% | -87.4% |
| Q3 2020 | $37,225,000 | +423.5% | 679,281 | +449.6% | 0.19% | +315.2% |
| Q2 2020 | $7,111,000 | +233.1% | 123,585 | +132.6% | 0.05% | +170.6% |
| Q1 2020 | $2,135,000 | -61.6% | 53,136 | -86.7% | 0.02% | -32.0% |
| Q1 2019 | $5,556,000 | +3438.9% | 400,000 | +1961.9% | 0.02% | +2400.0% |
| Q4 2015 | $157,000 | +5133.3% | 19,400 | +4750.0% | 0.00% | – |
| Q2 2015 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |